Description

NOVENTRA PHARMA – TIRRETA VIAL 60MG

Dual-Pathway Fat Loss Vial

Tirzepatide 30mg + Retatrutide 30mg

Serious appetite control. Serious fat loss.

Extreme appetite suppression

Targets GLP-1 + GIP + Glucagon receptors

Accelerated fat oxidation

Improves blood glucose control

Reduces food noise & binge eating

Helps preserve lean muscle during cut

Technical Specifications:

Composition: 30mg Tirzepatide + 30mg Retatrutide

Receptor Targets: GLP-1, GIP and Glucagon

Format: Multi-dose Vial

NOVENTRA HYBRID COMPOUND PEPTIDE VIAL (TIRZEPATIDE+RETATRUTIDE) 60MG